Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Risk of severe COVID-19 infection in kidney transplant recipients
Sacristán et al., Transplantation Proceedings, doi:10.1016/j.transproceed.2021.08.060
Sacristán et al., Risk of severe COVID-19 infection in kidney transplant recipients, Transplantation Proceedings, doi:10.1016/j.transproceed.2021.08.060
Nov 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 63 COVID+ kidney transplant recipients, showing significantly lower vitamin D levels before infection in patients requiring ICU admission.
Sacristán et al., 12 Nov 2021, peer-reviewed, 9 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Journal Pre-proof RISK OF SEVERE COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS Pilar Galindo Sacristán , Elena Clavero Garcı́a , Elisa Berta Pereira , Almudena Pérez Marfil , Marı́a José Torres Sánchez , José Manuel Osorio Moratalla , Carmen De Gracia Guindo , Marı́a Carmen Ruiz Fuentes , Antonio Osuna Ortega PII: DOI: Reference: S0041-1345(21)00806-X https://doi.org/10.1016/j.transproceed.2021.08.060 TPS 30693 To appear in: Transplantation Proceedings Please cite this article as: Pilar Galindo Sacristán , Elena Clavero Garcı́a , Elisa Berta Pereira , Almudena Pérez Marfil , Marı́a José Torres Sánchez , José Manuel Osorio Moratalla , Carmen De Gracia Guindo , Marı́a Carmen Ruiz Fuentes , Antonio Osuna Ortega , RISK OF SEVERE COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS, Transplantation Proceedings (2021), doi: https://doi.org/10.1016/j.transproceed.2021.08.060 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2021 Published by Elsevier Inc. TITLE: “RISK OF SEVERE COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS” AUTHORS: Pilar Galindo Sacristán1, Elena Clavero García1, Elisa Berta Pereira Pérez1, Almudena Pérez Marfil1, María José Torres Sánchez1, José Manuel Osorio Moratalla1, Carmen De Gracia Guindo1, María Carmen Ruiz Fuentes1, Antonio Osuna Ortega1. 1 Department of Nephrology. Virgen de las Nieves Universitary Hospital. Granada. Spain EMAIL ADDRESSES: pgalindosacristan@gmail.com (Pilar Galindo Sacristán) elena.clavero.sspa@juntadeandalucia.es (Elena Clavero García) elisapereirap@gmail.com (Elisa Berta Pereira Pérez) aperezmarfil@yahoo.es (Almudena Pérez Marfil) mjtosan@gmail.com (María José Torres Sánchez) josem.osorio.sspa@juntadeandalucia.es (José Manuel Osorio Moratalla) degraciaguindo@gmail.com (Carmen De Gracia Guindo) mcarmenrf2005@gmail.com (María Carmen Ruiz Fuentes) aosunaortega@ugr.es (Antonio Osuna Ortega) INSTITUTION ADDRESS: 2 Fuerzas Armadas AVE, Granada, 18014 INSTITUTION TELEPHONE: +34 958020000 MAIN AUTHOR: Pilar Galindo Sacristán ; pgalindosacristan@gmail.com ; +34626648738 KEY WORDS: COVID, immunosuppression, predictors GRANT SUPPORT: NO INTRODUCTION: Despite all efforts, the incidence of severe COVID infection has been high in renal transplant recipients, as in other groups (elderly, patients with comorbidities or immunosuppression). The detection of any possible predictor of gravity could improve the early approach in these patients. PATIENTS AND METHODS: We registered data from renal transplant recipients with SARS-COVID infection in our area during a year (March 2020-2021). We collected demographics, comorbidity, body mass index, lymphocyte count and vitamin D level before the diagnosis. We performed statistical analysis using SSPS.20. RESULTS: Of 63 patients, 57.1% required hospital admission and 14.3% intensive care. The incidence of acute renal failure was 28.6%. 34.9% developed hyperinflammatory syndrome. 67% had lymphopenia, which was severe in 13.1%...
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit